Hematologist-Oncologist
Akyavta Kallam, M.D., found her calling in medicine following in the footsteps of her mother, who is a gynecologist. Dr. Kallam’s specialty in oncology/hematology gives her the privilege of making a meaningful difference in the lives of patients and families. As a physician-scientist, she embraces the chance to be part of leading-edge research and see the benefits firsthand. As an oncologist/hematologist specializing in lymphoma, she has experience and expertise in novel immunotherapies, CAR T cell therapy and stem cell transplantation. Her research is focused on developing and evaluating novel immunotherapies and targeted therapies for the treatment of non-Hodgkin and Hodgkin lymphoma.
When Dr. Kallam became part of City of Hope’s faculty in 2023, she had co-authored 41 peer-reviewed scientific studies, was the principal investigator of four ongoing clinical trials and was a sub-investigator on 22 more. She has published articles about precision medicine and targeted therapies in the journals New England Journal of Medicine, Lancet Oncology and Expert Review of Hematology. She also contributes to care guidelines for blood cancers through her service on panels of the National Comprehensive Cancer Network. Before City of Hope, she was an assistant professor of hematology/oncology at the University of Nebraska.
Away from the lab and clinic, Dr. Kallam likes to travel, practice yoga, explore new cuisines and spend time with family.